Conference report demonstrates community growth and adoption of open-source modeling tools across pharmaceutical stakeholders, highlighting advances in model-informed drug development.
In 2017, the free and open-source software Open Systems Pharmacology (OSP) was launched. Since then, OSP has evolved from a small community into a diverse network of stakeholders committed to advancing open-source solutions for model-informed drug development (MIDD). In this context, the first OSP Community Conference was hosted by Novartis in Basel, Switzerland, on October 7-8, 2024, which gathered over 100 attendees from more than 40 institutions. This perspective synthesizes key insights from the conference.
No takes yet. Share an insight, caveat, or question.
Dallmann et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: